Immunotherapy

(ISSN: 1750-743X,1750-7448)

Mission Statement

Test The field of immunotherapy is moving forward at an unprecedented rate, and a range of therapeutic approaches are now used in clinical practice, often with outstanding success. The valuable role of immunotherapy in oncology is increasingly recognized alongside conventional chemo- and radio-therapies, and the US Food and Drug Administration has approved the use of immunotherapy in melanoma, leukemias, lymphomas and myelomas, and in breast, cervical, ovarian, kidney, prostate and colorectal cancers. Immunotherapeutics are also being applied in a variety of other disease areas, including allergy, rheumatoid disease, autoimmunity and transplantation, as well as in many infections, such as HIV/AIDS and hepatitis.

Many aspects of the immune system and mechanisms of immune-modulated therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. Immunotherapy offers the scientific community an interdisciplinary forum, providing them with concise and most recent advances of various aspects of immunotherapeutics to aid navigation of this complex field.

Articles published in Immunotherapy include key areas such as:

• Cancer immunotherapy, including cancer vaccines and passive immunotherapeutic approaches
• Combined chemo/radioimmunotherapy in cancer treatment
• Restorative immunotherapy for AIDS and other immunocompromised patients
• Suppressive immunotherapy for autoimmunity diseases and transplantation
• Allergy vaccines
• Basic science of immunotherapeutic approaches
• Drug-immune system interactions
• Drug delivery systems, drug combinations and drug-drug interactions
• Summaries evaluating newly approved immunotherapeutic agents
• Newly identified immune targets of drugs
• Results of recent findings and clinical trials relevant to the field of immunotherapy
• Postmarketing research, including adverce events, drug safety, pharmacoeconomics and cost-benefit issues

Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research.

Contact Information

http://www.futuremedicine.com/feedback/show

Subscription Information

http://www.futuremedicine.com/page/subscribe.jsp

Reprints & Supplements

http://www.futuremedicine.com/page/reprints.jsp

Editorial Advisory Board

Information about the Editorial Board is available at: http://www.futuremedicine.com/page/journal/imt/editors.jsp

Indexing Information

http://www.futuremedicine.com/page/indexing

Author Guidelines

Instructions for authors are available at: http://www.futuremedicine.com/page/authors.jsp

Journal Information